Wikidata

(Q33385533)

English

A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma

scientific article

In more languages

Statements

title
A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19633847
retrieved
26 July 2017
author name string
Monica Galli
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
19633847
retrieved
26 July 2017
Silvia Salmoiraghi
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
19633847
retrieved
26 July 2017
Antonella Gozzini
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
19633847
retrieved
26 July 2017
Claudia Crippa
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
19633847
retrieved
26 July 2017
Norbert Pescosta
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
19633847
retrieved
26 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33385533&oldid=1957466993"